Entrada Therapeutics Inc. (TRDA)
NASDAQ · Healthcare
Entrada Therapeutics Inc. EPS 2023–2025
Entrada Therapeutics Inc. annual/quarterly eps history and growth rate from 2023 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Entrada Therapeutics Inc. eps for the quarter ending March 31, 2026 was $0.95, a 126.19% increase year-over-year.
- Entrada Therapeutics Inc. annual eps for 2025 was $3.47, a 306.55% decrease from 2024.
- Entrada Therapeutics Inc. annual eps for 2024 was $1.68, a 940.00% decrease from 2023.
- Entrada Therapeutics Inc. annual eps for 2023 was $0.20.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Entrada Therapeutics Inc. EPS — FAQ
Entrada Therapeutics Inc. (TRDA) eps over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Entrada Therapeutics Inc.'s eps?
Entrada Therapeutics Inc. (TRDA) reported eps of $-3.47 for fiscal 2025.
Where can I see TRDA's eps history?
The chart and table above show Entrada Therapeutics Inc.'s eps by year and by quarter, including the growth rate.